IRCT20220529055013N1尚未招募4 期
Efficacy of Dapagliflozin in diabetic and nondiabetic patients with Acute heart failure
Public Sector medical University0 个研究点目标入组 160 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 no limit（—）
- 性别
- All
入选标准
- •1. Male/Female patients 30 years and above
- •2. Diagnosis of acute decompensated heart failure made on admission based on any two of the following signs and symptoms a)Dyspnea at rest or minimal exertion b)Peripheral edema c) Ascites d)5-pound weight gain (rapid) e) Signs of congestion on X-ray
- •3. Left ventricular Ejection fraction = 40%
- •4. eGFR = 30ml/min
排除标准
- •Cardiogenic shock;
- •urgent hospitalization for acute heart failure primarily triggered by pulmonary embolism ,cerebrovascular accident, or acute myocardial infarction
- •Current hospitalization for acute heart failure not caused primarily by intravascular volume overload
- •Type 1 Diabetes mellitus
- •History of Diabetic ketoacidosis
- •History of hepatic impairment
- •Known allergy to SGLT 2 inhibitors
- •Women pregnant or breast feeding
研究者
相似试验
已完成
不适用
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45
尚未招募
不适用
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25
已完成
不适用
Effect of Dapagliflozin in patients with type 2 daibetes mellitusType 2 diabetes mellitusJPRN-UMIN000014922Iwasaki Naika Clinic50
尚未招募
4 期
Assessment of Empagliflozin effects in coronary artery diseaseIRCT20190412043247N2Zanjan University of Medical Sciences100
招募中
2 期
A single-site study of the effectiveness of Dapagliflozin for diabetic patients admitted to the intensive care unitMetabolic and Endocrine - DiabetesDiabetesACTRN12621001102864Austin Health40